Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001302

Options or other derivatives

  • Chief Financial Officer acquired 1,538,640 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Rawcliffe Adrian Chief Financial Officer 2019-01-04 Grant or award · Option to purchase Ordinary Shares +1,257,744 1,257,744 D
Rawcliffe Adrian Chief Financial Officer 2019-01-04 Grant or award · Option to purchase Ordinary Shares +280,896 280,896 D
Loading xslF345X03/a4.xml…